A. DUNAISKIS

596 total citations
8 papers, 483 citations indexed

About

A. DUNAISKIS is a scholar working on Organic Chemistry, Pharmacology and Biological Psychiatry. According to data from OpenAlex, A. DUNAISKIS has authored 8 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Pharmacology and 2 papers in Biological Psychiatry. Recurrent topics in A. DUNAISKIS's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Chemical synthesis and alkaloids (3 papers) and Stress Responses and Cortisol (2 papers). A. DUNAISKIS is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Chemical synthesis and alkaloids (3 papers) and Stress Responses and Cortisol (2 papers). A. DUNAISKIS collaborates with scholars based in United States. A. DUNAISKIS's co-authors include Robert S. Mansbach, David W. Schulz, Michael L. Corman, Anne W. Schmidt, J.L. Collins, P A Seymour, James Heym, Thomas Seeger, John P. Braselton and Jeffrey Sprouse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

A. DUNAISKIS

7 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. DUNAISKIS United States	5	355	145	135	133	108	8	483
J.L. Collins United States	4	273 0.8×	118 0.8×	99 0.7×	108 0.8×	171 1.6×	4	456
Toshihito Kumagai Japan	10	150 0.4×	69 0.5×	81 0.6×	58 0.4×	190 1.8×	18	433
Yuhpyng L. Chen United States	11	312 0.9×	125 0.9×	156 1.2×	127 1.0×	139 1.3×	15	782
Irene Gracia‐Rubio Spain	11	128 0.4×	89 0.6×	98 0.7×	23 0.2×	80 0.7×	24	500
Thangaraj Devadoss India	16	134 0.4×	40 0.3×	170 1.3×	14 0.1×	149 1.4×	38	616
Kenneth W. Rohrbach United States	11	64 0.2×	47 0.3×	31 0.2×	35 0.3×	117 1.1×	17	288
Izyaslav P. Lapin Russia	11	59 0.2×	45 0.3×	107 0.8×	20 0.2×	159 1.5×	16	438
Ank Frankhuijzen-Sierevogel Netherlands	12	110 0.3×	140 1.0×	30 0.2×	17 0.1×	32 0.3×	15	403
Tobias Deiml Germany	6	56 0.2×	21 0.1×	53 0.4×	97 0.7×	66 0.6×	7	368
Herlinda Bonilla Jaime Mexico	6	82 0.2×	38 0.3×	70 0.5×	18 0.1×	60 0.6×	9	365

Countries citing papers authored by A. DUNAISKIS

Since Specialization

Citations

This map shows the geographic impact of A. DUNAISKIS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. DUNAISKIS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. DUNAISKIS more than expected).

Fields of papers citing papers by A. DUNAISKIS

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. DUNAISKIS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. DUNAISKIS. The network helps show where A. DUNAISKIS may publish in the future.

Co-authorship network of co-authors of A. DUNAISKIS

This figure shows the co-authorship network connecting the top 25 collaborators of A. DUNAISKIS. A scholar is included among the top collaborators of A. DUNAISKIS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. DUNAISKIS. A. DUNAISKIS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Chappie, Thomas A., A. DUNAISKIS, Anton Fliri, et al.. (1998). Synthesis, sar and pharmacology of CP-293,019: A potent, selective dopamine D4 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(7). 725–730. 28 indexed citations

Chen, Yuhpyng L., Robert S. Mansbach, Steven M. Winter, et al.. (1997). Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally Active Corticotropin-Releasing Factor₁ Receptor Antagonist. Journal of Medicinal Chemistry. 40(11). 1749–1754. 93 indexed citations

Schulz, David W., Robert S. Mansbach, Jeffrey Sprouse, et al.. (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.. Proceedings of the National Academy of Sciences. 93(19). 10477–10482. 308 indexed citations

DUNAISKIS, A., et al.. (1995). LARGE SCALE SYNTHESIS OF 2-CHLORO-5-FLUOROPYRIMIDINE. Organic Preparations and Procedures International. 27(5). 600–602. 1 indexed citations

Liston, Dane, Jonas B. Nielsen, Douglas S. Chapin, et al.. (1994). Syntheses and Anticholinesterase Activity of Tetrahydrobenzazepine Carbamates. Journal of Medicinal Chemistry. 37(13). 1996–2000. 12 indexed citations

Liston, Dane, J.A. Nielsen, Douglas S. Chapin, et al.. (1994). ChemInform Abstract: Syntheses and Anticholinesterase Activity of Tetrahydrobenzazepine Carbamates.. ChemInform. 25(50). 1 indexed citations

Nielsen, J.A., A. DUNAISKIS, Shawn B. Jones, et al.. (1993). ChemInform Abstract: Syntheses, Resolution, and Structure—Activity Relationships of Potent Acetylcholinesterase Inhibitors: 8‐Carbaphysostigmine Analogues.. ChemInform. 24(1). 1 indexed citations

Nielsen, Jonas B., Karen K. Hedberg, A. DUNAISKIS, et al.. (1992). Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogs. Journal of Medicinal Chemistry. 35(8). 1429–1434. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact